Compared with SelectMDx, another well‐known urine marker study for prostate cancer,34 our Shengli training cohort showed that the UCA1 score had a better AUC (0.880 vs. 0.76) and PPV (0.67 vs. 0.27). This evidence concerns the gene UCA1 and prostate carcinoma.